K.M.A. Welch
About
In The Last Decade
K.M.A. Welch
163 papers receiving 6.6k citations
Peers
Comparison fields: 5 of 136
- Psychiatry and Mental health 3.8k
- Pathology and Forensic Medicine 1.7k
- Physiology 1.4k
- Neurology 1.3k
- Neurology 1.2k
Countries citing papers authored by K.M.A. Welch
This map shows the geographic impact of K.M.A. Welch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.M.A. Welch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.M.A. Welch more than expected).
Fields of papers citing papers by K.M.A. Welch
This network shows the impact of papers produced by K.M.A. Welch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.M.A. Welch. The network helps show where K.M.A. Welch may publish in the future.
Co-authorship network of co-authors of K.M.A. Welch
This figure shows the co-authorship network connecting the top 25 collaborators of K.M.A. Welch. A scholar is included among the top collaborators of K.M.A. Welch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.M.A. Welch. K.M.A. Welch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Abstract 2173: Effect of High-dose Atorvastatin on Changes in Renal Function: A Secondary Analysis of the Stroke Prevention by Aggressive Reduction of Cholesterol Levels (SPARCL) Trial | 1 |
| 2 | Abstract 2985: Lipoprotein, Blood Pressure and Stroke Risk: Findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study | 3 |
| 3 | Correspondence "Statin Therapy after Stroke or Transient Ischemic Attack" The authers reply | 0 |
| 4 | 272 | |
| 5 | 3 | |
| 6 | 158 | |
| 7 | 31 | |
| 8 | 29 | |
| 9 | 137 | |
| 10 | 2 | |
| 11 | 44 | |
| 12 | INVESTIGATION OF BRAIN ISCHEMIA IMAGING BY MR DIFFUSION | 1 |
| 13 | 19 | |
| 14 | 55 | |
| 15 | 75 | |
| 16 | 91 | |
| 17 | 9 | |
| 18 | 8 | |
| 19 | 2 | |
| 20 | 28 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.